Product Images Keppra
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 12 images provide visual information about the product associated with Keppra NDC 50474-596 by Ucb, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This appears to be a table showing the percentage of patients taking two different dosages of the medication KEPPRA (1000 mg/day and 3000 mg/day). The table includes three percentages and then shows the percentages for the two groups of patients (N=97 and N=101) taking the respective dosages. There is not enough context to determine what the percentages represent or what condition the medication is being used to treat.*
This appears to be a table or chart with percentages and numbers related to two different dosages of the medication Keppra. However, without more context or information it is difficult to provide a more useful description.*
This text provides data on the percentage of patients in a clinical trial who received either placebo or KEPPRA. The percentage of patients who received KEPPRA was 19.6%, while the percentage who received placebo was 44.6%. The sample sizes for these groups were N=101 and N=7 respectively.*
This text is a medication label for Levitiracetam, which is being sold under the brand name KEPPRA. The label provides instructions to the pharmacist to dispense the medication in a tight, light-resistant container with a package insert for complete dosage recommendations. Patients must be given an accompanying medication guide. The medication should be stored at 25°C with excursions permitted to 15-30°C. The label provides the product details, including PT# CIP70127 and NDC 50474-594-40 for 120 tablets of 250mg strength. KEPPRA is a trademark of UCB S.A., and the product is manufactured in Smyrna, GA, 30080.*
This is a medication label for Levitiracetam tablets, with a recommended storage temperature of 25°C (77°F), stored in a tight and light-resistant container with child-resistant closures. The label instructs pharmacists to include a medication guide with each patient's prescription and to refer to the package insert for complete dosage recommendations. The medication is manufactured for UCB, Inc. in Smyrna, GA and is a registered trademark under the name KEPPRA.*
This text describes instructions for dispensing and storing medication in a container with child-resistant closure. It also provides information about the usual dosage and storage conditions for the medication, as well as the manufacturer's details and trademark. The text also includes a PT number and NDC number which may be useful for identification purposes. It recommends dispensing an accompanying Medication Guide to every patient.*
Usual Dosage: See package insert for complete dosage recommendations. This is a 100mg/mL oral solution of levetiracetam manufactured by V.P for bucs, inc. This medication should be dispensed with an accompanying medication guide to each patient. It comes in a 16 fl oz (473 mL) bottle and the pharmacist should dispense it in a tight, light-resistant container with a child-resistant closure. It must be stored at 25°C with some excursions allowed up to 15-30°C. Keep this and all medications out of the reach of children.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.